Many pharmaceutical companies are working on ebola vaccines and ebola cures….they’re all over the news. For example:
http://www.marketwatch.com/story/2-ebola-stocks-to-sell-and-5-to-consider-buying-2014-10-13?page=2
Excerpt:
“Stocks to Buy
“All small Ebola-related stocks are highly speculative and carry extremely high risk of loss. Most promising are companies that are working on vaccines. If a vaccine is successfully developed, it may quickly become a sustainable big business. Two companies of note are NewLink Genetics NLNK, +22.56% and Inovio Pharmaceuticals INO, +5.69%
“A company such as Tekmira Pharmaceuticals TKMR, -3.23% carries a very high risk because its Ebola drug may or may not work and its other programs are in very early stages while the stock price has rocketed on speculation.
“Companies such as BioCryst Pharmaceuticals BCRX, +3.18% Sarepta Therapeutics SRPT, +6.22% and Chimerix CMRX, +9.63% carry less risk than Tekmira because their programs are more advanced.
“In general, buying stocks based on their potential Ebola drugs may be a good trade but likely to be a bad investment because even if there is a successful drug, after the initial stockpiling the market size is limited.”
I wish to heck I’d bought Tekmira two months ago when it was selling at $13. Had a nice run up to $30 but now it’s dropped back.
Further to my post #55. Tekmira’s product is a vaccine. Monsanto has invested in it, which means it’s a promising drug.